Terms: = Colorectal cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Prognosis
342 results:
1. The Relationship of Microsatellite Instability with BRAF and p53 Mutations and Histopathological Parameters in colorectal Adenocarcinoma.
Gündoğar Ö; Bektaş S; Yıldırım E; Gönüllü D
Ann Ital Chir; 2024; 95(2):181-191. PubMed ID: 38684491
[TBL] [Abstract] [Full Text] [Related]
2. Microenvironment, systemic inflammatory response and tumor markers considering consensus molecular subtypes of colorectal cancer.
Jakab A; Patai ÁV; Darvas M; Tormássi-Bély K; Micsik T
Pathol Oncol Res; 2024; 30():1611574. PubMed ID: 38645565
[No Abstract] [Full Text] [Related]
3. Pan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours.
Chen Y; Gao Z; Mohd-Ibrahim I; Yang H; Wu L; Fu Y; Deng Y
Clin Transl Med; 2024 Feb; 14(2):e1543. PubMed ID: 38303608
[TBL] [Abstract] [Full Text] [Related]
4. Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications.
Addante F; d'Amati A; Santoro A; Angelico G; Inzani F; Arciuolo D; Travaglino A; Raffone A; D'Alessandris N; Scaglione G; Valente M; Tinnirello G; Sfregola S; Padial Urtueta B; Piermattei A; Cianfrini F; Mulè A; Bragantini E; Zannoni GF
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256131
[TBL] [Abstract] [Full Text] [Related]
5. Effects of tumour budding on adjuvant chemotherapy in colorectal cancer.
Xie H; Zeng Z; Hou Y; Ye F; Cai T; Cai Y; Xiong L; Li W; Liu Z; Liang Z; Luo S; Zheng X; Huang L; Liu H; Kang L
BJS Open; 2024 Jan; 8(1):. PubMed ID: 38190579
[TBL] [Abstract] [Full Text] [Related]
6. Association of Geriatric Nutritional Risk Index With Adverse Event and Treatment Duration in Adjuvant Chemotherapy for Patients With colorectal cancer.
Shimizu A; Fukasawa M; Endo R; Nakamura T; Yamada S; Fujibayashi R; Kikuchi K; Tanaka M; Hasegawa I; Sato H
In Vivo; 2024; 38(1):453-459. PubMed ID: 38148079
[TBL] [Abstract] [Full Text] [Related]
7. [Analysis of clinicopathological features and prognosis of sporadic synchronous multiple primary colorectal cancers].
Qin ZF; Xu GH; Zhou SQ; Zheng PW; Zhu YP; Ju HX; Li DC; Ma DN
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Dec; 26(12):1171-1178. PubMed ID: 38110279
[No Abstract] [Full Text] [Related]
8. Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high colorectal cancer after Treatment Termination.
Simmons K; Thomas JV; Ludford K; Willis JA; Higbie VS; Raghav KPS; Johnson B; Dasari A; Kee BK; Parseghian CM; Lee MS; Le PH; Morelli MP; Shen JP; Bent A; Vilar E; Wolff RA; Kopetz S; Overman MJ; Morris VK
Cancer Res Commun; 2023 Dec; 3(12):2510-2517. PubMed ID: 38085001
[TBL] [Abstract] [Full Text] [Related]
9. Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial.
Desai J; Alonso G; Kim SH; Cervantes A; Karasic T; Medina L; Shacham-Shmueli E; Cosman R; Falcon A; Gort E; Guren T; Massarelli E; Miller WH; Paz-Ares L; Prenen H; Amatu A; Cremolini C; Kim TW; Moreno V; Ou SI; Passardi A; Sacher A; Santoro A; Stec R; Ulahannan S; Arbour K; Lorusso P; Luo J; Patel MR; Choi Y; Shi Z; Mandlekar S; Lin MT; Royer-Joo S; Chang J; Jun T; Dharia NV; Schutzman JL; ; Han SW
Nat Med; 2024 Jan; 30(1):271-278. PubMed ID: 38052910
[TBL] [Abstract] [Full Text] [Related]
10. Survival outcomes in locally advanced dMMR rectal cancer: surgery plus adjunctive treatment vs. surgery alone.
Ni K; Zhan Y; Liu Z; Yuan Z; Wang S; Zhao XZ; Ping H; Liu Y; Wang W; Yan S; Xin R; Han Q; Zhang Q; Li G; Zhang X; Wang G; Zhang Z; Ma H; Zhang C
BMC Cancer; 2023 Oct; 23(1):1013. PubMed ID: 37864137
[TBL] [Abstract] [Full Text] [Related]
11. MRI-based Multiregional Radiomics for Pretreatment Prediction of Distant Metastasis After Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal cancer.
Zhao R; Wan L; Chen S; Peng W; Liu X; Wang S; Li L; Zhang H
Acad Radiol; 2024 Apr; 31(4):1367-1377. PubMed ID: 37802671
[TBL] [Abstract] [Full Text] [Related]
12.
Tobi M; Weinstein D; Kim M; Hatfield J; Sochacki P; Levi E; An T; Hamre M; Tolia V; Fligiel S; Marepally R; Hallman J; Bapat B; Yuan M; McVicker B; Gallinger S
Curr Oncol; 2023 Aug; 30(9):7950-7963. PubMed ID: 37754493
[TBL] [Abstract] [Full Text] [Related]
13. Mismatch Repair Deficiency in Biliary Tract cancer: Prognostic Implications and Correlation with Histology.
Vivaldi C; Genovesi V; Ugolini C; Bernardini L; Casadei-Gardini A; Formica V; Salani F; Orsi G; Massa V; Cacciato-Insilla A; Caccese M; Cesario S; Andrikou K; Graziani J; Campani D; Vasile E; Fontanini G; Fornaro L; Masi G
Oncology; 2024; 102(2):157-167. PubMed ID: 37699372
[TBL] [Abstract] [Full Text] [Related]
14. Co-Occurrence of Germline Genomic Variants and Copy Number Variations in Hereditary Breast and colorectal cancer Patients.
Côrtes L; Basso TR; Villacis RAR; Souza JDS; Jørgensen MMA; Achatz MI; Rogatto SR
Genes (Basel); 2023 Aug; 14(8):. PubMed ID: 37628631
[TBL] [Abstract] [Full Text] [Related]
15. Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: an ACCENT/IDEA pooled analysis of seven trials.
Taieb J; Sinicrope FA; Pederson L; Lonardi S; Alberts SR; George TJ; Yothers G; Van Cutsem E; Saltz L; Ogino S; Kerr R; Yoshino T; Goldberg RM; André T; Laurent-Puig P; Shi Q
Ann Oncol; 2023 Nov; 34(11):1025-1034. PubMed ID: 37619846
[TBL] [Abstract] [Full Text] [Related]
16. Extramural Venous Invasion and Tumor Deposit at Diffusion-weighted MRI in Patients after Neoadjuvant Treatment for Rectal cancer.
Kim TH; Firat C; Thompson HM; Gangai N; Zheng J; Capanu M; Bates DDB; Paroder V; García-Aguilar J; Shia J; Gollub MJ; Horvat N
Radiology; 2023 Aug; 308(2):e230079. PubMed ID: 37581503
[TBL] [Abstract] [Full Text] [Related]
17. Sintilimab plus bevacizumab and CapeOx (BBCAPX) on first-line treatment in patients with RAS mutant, microsatellite stable, metastatic colorectal cancer: study protocol of a randomized, open-label, multicentric study.
Fang X; Zhong C; Weng S; Hu H; Wang J; Xiao Q; Wang J; Sun L; Xu D; Liao X; Dong C; Zhang S; Li J; Ding K; Yuan Y
BMC Cancer; 2023 Jul; 23(1):676. PubMed ID: 37464378
[TBL] [Abstract] [Full Text] [Related]
18. Immuno-PET of colorectal cancer with a CEA-targeted [68 Ga]Ga-nanobody: from bench to bedside.
Li L; Lin X; Wang L; Ma X; Zeng Z; Liu F; Jia B; Zhu H; Wu A; Yang Z
Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3735-3749. PubMed ID: 37382662
[TBL] [Abstract] [Full Text] [Related]
19. Concordance in detection of microsatellite instability by PCR and NGS in routinely processed tumor specimens of several cancer types.
Bartels S; Grote I; Wagner M; Boog J; Schipper E; Reineke-Plaass T; Kreipe H; Lehmann U
Cancer Med; 2023 Aug; 12(16):16707-16715. PubMed ID: 37376830
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic value of Lynch syndrome, BRAF
Zwart K; van der Baan FH; Cohen R; Aparicio T; de la Fouchardiére C; Lecomte T; Punt CJA; Sefrioui D; Verheijden RJ; Vink GR; Wensink GE; Zaanan A; Koopman M; Tougeron D; Roodhart JML
Cancer Med; 2023 Aug; 12(15):15841-15853. PubMed ID: 37326121
[TBL] [Abstract] [Full Text] [Related]
[Next]
